Preserved vasodilatory response to nitroglycerin in saphenous vein bypass grafts

Circulation

Volumn 94, Issue 11, 1996, Pages 2871-2876

  Berglund, Hans ^a   Luo, Huai ^b   Nishioka, Toshihiko ^b   Eigler, Neal L ^b   Kim, Chong Jin ^b   Tabak, Steven W ^b   Siegel, Robert J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; coronary disease; grafting; nitroglycerin; ultrasonics; vasodilation

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECT; ECHOGRAPHY; FEMALE; HUMAN; MALE; PRESERVATION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE RELAXATION; VASA VASORUM; VASODILATATION;

EID: 0029819367     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2871     Document Type: Article

References (21)

1. Vlodaver Z, Edwards JE. Pathological changes in aortic-coronary arterial saphenous vein grafts. Circulation. 1971;47:719-728.
2. Unni KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. Pathological changes in aortocoronary saphenous vein grafts. Am J Cardiol. 1974;34:526-532.
3. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis: anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol. 1977;40:906-914.
4. Campeau L, Enjalbert M, Lespérance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks. 1 year. 5 to 7 years, and 10 to 12 years after surgery. Circulation. 1983:68(suppl II):II-1-II-7.
5. Spray TL, Roberts WC. Changes in saphenous veins used as aortocoronary bypass grafts. Am Heart J. 1977;94:500-516.
6. Angelini GD, Newby AC. The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J. 1989;10:273-280.
7. Yamagishi M, Nissen SE, Booth DC, Gurley JC, Koyama J, Kawano S, DeMaria AN. Coronary reactivity to nitroglycerin: intravascular ultrasound evidence for the importance of plaque distribution. J Am Coll Cardiol. 1995;25:224-230.
8. Nissen SE, Grines CL, Gurley JC, Booth DC, McClure R, Berk M, Fischer C, DeMaria AN. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087-1099.
9. Tobis JM, Mallery J, Mahon D, Lehman K, Zalesky P, Griffith J, Gessert J, Moriuchi M, McRae M, Dwyer ML, Greep N, Henry WL. Intravascular ultrasound imaging of human coronary arteries: in vivo analyses of tissue characterizations with comparison to in vitro histological specimens. Circulation. 1991;83:913-926.
10. Yock PG, Johnson EL, Linker DT. Intravascular ultrasound: development and clinical potential. Am J Card Imaging. 1988;2:185-193.
11. Nissen SE, Grines CL, Gurley JC, Sublett K, Haynie D, Diaz C, Booth DC, DeMaria AN. Application of new phased array ultrasound imaging catheter in the assessment of vascular dimensions: in vivo comparison with cineangiography. Circulation. 1990;81:660-666.
12. Hanet C, Robert A. Wijns W. Vasomotor response to ergotamine and nitrates of saphenous vein grafts, internal mammary artery grafts, and grafted coronary arteries after bypass surgery. Circulation. 1992; 86(suppl II):II-210-II-216.
13. Jett GK, Arcici JM, Hatcher CR, Abel PW, Guyton RA. Vasodilator drug effects on internal mammary artery and saphenous vein grafts. J Am Coll Cardiol. 1988;11:1317-1324.
14. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation. 1981;64:1089-1097.
15. Pinto FJ, St Goar FG, Fischell TA, Stadius ML, Valantine HA, Alderman EL, Popp RL. Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients: evaluation with in vivo intracoronary ultrasound. Circulation. 1992;85:69-77.
16. Ku DD, Caulfield JB, Kirklin JK. Endothelium-dependent response in long-term human coronary artery bypass grafts. Circulation. 1991; 83:402-411.
17. Cross KS, Davies MG, El-Sanadiki MN, Murray JJ, Mikat EM, Hagen P-O. Long-term human vein graft contractility and morphology: a functional and histopathological study of retrieved coronary vein grafts. Br J Surg. 1994;81:699-705.
18. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal humaṅ coronary arteries to injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482-490.
19. Ready KG, Nair RN, Sheean HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833-843.
20. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr. Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol. 1995;26:41-49.
21. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990;16:349-356.